Brooks Laboratories Limited (BOM:533543)
India · Delayed Price · Currency is INR 60.14
+5.46 (9.99%)
At close: Oct 6, 2026
Brooks Laboratories Market Cap
Brooks Laboratories has a market cap or net worth of 1.76 billion as of October 7, 2026. Its market cap has decreased by 54.39% in one year.
Market Cap
1.76B
Enterprise Value
1.78B
Revenue
831.87M
Global Rank
n/a
Country Rank
n/a
PE Ratio
13.30
ChartMarket Cap Chart
Since September 5, 2011, Brooks Laboratories's market cap has increased from 105.21M to 1.76B, an increase of 1,570.36%. That is a compound annual growth rate of 20.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 1.73B | -26.65% |
| Dec 31, 2025 | 2.36B | -50.07% |
| Dec 31, 2024 | 4.73B | 25.45% |
| Dec 29, 2023 | 3.77B | 39.59% |
| Dec 30, 2022 | 2.70B | 8.92% |
| Dec 31, 2021 | 2.48B | 51.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Accretion Pharmaceuticals | 2.16B |
| Sanjivani Paranteral | 2.04B |
| Coral Laboratories | 2.01B |
| Bio Medica Laboratories | 2.01B |
| Medico Remedies | 1.81B |
| Kerala Ayurveda | 1.77B |
| Oxygenta Pharmaceutical | 1.74B |
| Bal Pharma | 1.71B |